Tag: pharmaceuticals
-

Trial to Test Many Covid-19 Lung Disease Treatments
A clinical trial designed to make quick changes to accommodate new conditions plans to assess 10 to 20 drugs for a serious lung complication from Covid-19 infections.
-

Limited Covid-19 Benefits Found for Arthritis Drug
A clinical trial testing an arthritis drug to treat Covid-19 patients shows the drug helps the most critical patients, but not others with advanced infections.
-

Psychiatric Drug Maker Raises $80M in Venture Funds
A developer of treatments for mental health disorders based on controlled hallucinogenic substances is raising $80 million in new venture financing.
-

World Leaders Back WHO Covid-19 Plans, U.S. Absent
Several international leaders took part today in a virtual conference on accelerating and focusing World Health Organization’s efforts to combat Covid-19 infections.
-

Trial Okayed in Germany for Covid-19 Vaccine
Regulators in Germany cleared a clinical trial to begin testing a vaccine with synthetic RNA to prevent coronaviruses from causing Covid-19 infections.
-

Moderna Gains $483M for Covid-19 Vaccine
A government preparedness agency awarded biotechnology company Moderna Inc. $483 million to advance its Covid-19 vaccine through clinical trials.
-

Covid-19 Antibody Therapy Prepares for Trial
A biotechnology company producing synthetic antibodies in cattle, without human blood, to treat Covid-19 infections is advancing the therapy toward a clinical trial.
-

Anti-Viral Drug Treats Some Severe Covid-19 Cases
A report of early use of the anti-viral therapy remdesivir shows most patients with severe cases of Covid-19 infections responded to the drug.
-

Five Covid-19 Vaccines in Clinical Trials
A review of vaccines for preventing Covid-19 infections shows five of those projects are in early-stage clinical trials, with 18 more in preclinical stage.
-

Covid-19 Vaccine in Development, Trial Planned
A biotechnology company specializing in infectious diseases is developing a vaccine to protect against Covid-19 infections, with a clinical trial to start next month.